Finance

Lists
Why is TTRX up 5,36%?
Dive Deeper
TTRX:NASDAQ
Turn Therapeutics Inc
12,00 USD
+5,36%
(+0,61) 1D
9-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TTRX...
Open
11,34 USD
High
12,00 USD
Low
11,30 USD
Mkt. cap
366,03 млн
Avg. vol.
150,33 миң
Volume
109,80 миң
52-wk high
16,45 USD
52-wk low
2,57 USD
EPS
-0,29 USD
Shares outstanding
29,79 млн
No. of employees
2
Open
11,34 USD
High
12,00 USD
Low
11,30 USD
Mkt. cap
366,03 млн
Avg. vol.
150,33 миң
Volume
109,80 миң
52-wk high
16,45 USD
52-wk low
2,57 USD
EPS
-0,29 USD
Shares outstanding
29,79 млн
No. of employees
2
News stories
From web sources and news partners
About Turn Therapeutics Inc
CEO-
Employees2
Founded2015
HeadquartersУэстлейк Виллидж, Калифорния, Америка Кошмо Штаттары
SectorPharmaceutical industry
Analyst ratings
Based on 4 analysts giving stock ratings to TTRX in the past 3 months
Hold
Buy
2
Hold
0
Sell
2
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TTRX in the last 3 months.
Highest
Current 12,00 USD
24,00 USD (+100,00%)
Average
15,00 USD (+25,00%)
Lowest
10,00 USD (-16,67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dev Prasad
Lucid Capital
Buy
Initiated
24,00 USD
+100%
09/24/2026
Karen Sterling
Westpark Capital
Sell
Downgraded
10,00 USD
-16,7%
09/14/2026
Unknown Analyst
WBB Securities
Sell
Downgraded
10,00 USD
-16,7%
09/14/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Maintained
16,00 USD
+33,3%
08/13/2026
Jason Kolbert
D. Boral Capital
Buy
Initiated
8,00 USD
-33,3%
12/29/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
496,95 миң
477,65 миң
638,75 миң
Cost of revenue
-
496,95 миң
477,65 миң
638,75 миң
Research and development expenses
158,70 миң
34,93 миң
109,43 миң
475,06 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,75 млн
2,16 млн
1,14 млн
1,15 млн
Operating expense
1,91 млн
2,19 млн
1,25 млн
1,63 млн
Total operating expenses
1,91 млн
2,69 млн
1,72 млн
2,27 млн
Operating income
-1,91 млн
-2,69 млн
-1,72 млн
-2,27 млн
Other non operating income
4,26 миң
2,96 млн
703,14 миң
-3,34 млн
EBT including unusual items
-1,90 млн
279,07 миң
-970,97 миң
-5,85 млн
EBT excluding unusual items
-1,90 млн
279,07 миң
-970,97 миң
-5,85 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,90 млн
279,07 миң
-970,97 миң
-5,85 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-0,04
-
Interest and investment income
5,11 миң
14,18 миң
49,68 миң
-
Interest expense
-
-
-
-241,36 миң
Net interest expenses
5,11 миң
14,18 миң
49,68 миң
-241,36 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,90 млн
-2,68 млн
-1,71 млн
-2,25 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору